People Of Ages Research Articles

Undernutrition, socio-demographic characteristics and eating habits of the elderly

Ageing is often accompanied by a decrease of food consumption, possibly leading to undernutrition. A single nutritional study was conducted in 2011 in the general population, showing that 5.5% of people aged >65 years were undernourished. The aim of our study was to assess the prevalence of undernutrition in the elderly and its relationship with sociodemographic characteristics and dietary habits. A cross-sectional study was conducted on a representative sample of subjects aged ≥60 years in urban and rural areas of the country's eight administrative regions. A questionnaire including socio-demographic data, food consumption frequencies and anthropometric measurements was used. Student's t-test and Man Whitney test were used with a significance level of 5%. A multivariate analysis was performed between undernutrition and the other factors collected. 1698 older adults were included (male: 63.5%, sex ratio M/F=1.7), with a mean age of 71.6±9.4 years and a BMI of 22.6±4.4kg/m2. The prevalence of undernutrition was 14.4%. Undernutrition was significantly associated with age 80-89 years and ≥90 years, (p=0.0001 and p=0.0001 respectively), male sex (p=0.006), rural areas (p=0.002), being in activity (p=0.009) and fish consumption (p=0.039). Breakfast was consumed every day in 87.2% of cases, lunch in 74.3% and dinner in 83.2%. Rice and bread were the most consumed food. Early detection of nutritional disorders, nutritional education and promotion of a balanced diet could help improve the health of the elderly.

Emotional Reactions of Professionals to Challenging Behaviors in People with Intellectual and Developmental Disability.

Professionals working with people with intellectual and developmental disability (IDD) can be exposed to challenging behaviors (CBs), which may result in professionals exhibiting emotional reactions that can impact their practices. This study examined these reactions and analyzed how they are influenced by the individual characteristics of people with IDD (gender, age, and level of IDD) and the variables related to CB (type of behavior and its frequency and behavioral function). A total of 125 professionals assessed 293 people with IDD who exhibited CBs. The professionals were asked to complete the Behavior Problems Inventory-Short Form, the Emotional Reactions to Challenging Behavior Scale, and the Questions About Behavior Function measure. It was revealed that positive emotional reactions predominated over negative ones. Significant results were found regarding the level of disability and the age of people with IDD. Emotional reactions were related to the severity of CBs, especially self-injurious and aggressive/destructive behavior, as well as certain behavioral functions. The severity of CBs and the age of people with IDD emerge as key predictors of the emotional reactions of professionals. In short, these reactions vary according to different variables, highlighting the importance of interventions that address professionals' emotional needs.

End-of-life care in multiple system atrophy: UK survey of patients and families

ObjectivesPeople with multiple system atrophy (MSA) and their carers may have many concerns about their disease and the future. This survey of people with MSA and their carers aimed to...

In vitro effects of antidepressants on human sperm function.

Depression currently affects about 280 million people worldwide and its prevalence has been increasing dramatically, especially among the young and people of reproductive age, which consequently leads to an increase in antidepressant consumption. Antidepressants are associated with sexual dysfunction in both men and women; however, their role in male fertility has been scarcely studied. Fluoxetine and sertraline, two serotonin reuptake inhibitors (SSRIs), are among the most prescribed antidepressants worldwide. To determine their possible effects, human sperm cells were exposed to either sertraline or fluoxetine at concentrations previously found in blood and seminal fluid of patients undergoing treatment. Spermatozoa were incubated for up to 24 h at 37°C and 5% CO2, and important functional parameters such as sperm motility, viability, mitochondrial membrane potential, cellular reactive oxygen species (ROS) production, chromatin/DNA integrity, acrosome status, and tyrosine phosphorylation were assessed. At low levels, fluoxetine consistently decreased progressive motility throughout time while promoting fluctuations in ROS levels and sperm capacitation. Nevertheless, it did not affect viability, mitochondrial membrane potential, acrosome reaction nor chromatin/DNA integrity. Sertraline, on the other hand, had little to nonsignificant impact at low doses, but affected almost all tested parameters at supratherapeutic concentrations. Altogether, our results suggest that both antidepressants may impair sperm function, possibly through different mechanisms of action, but fluoxetine is the only exhibiting mild negative effects at doses found in vivo.

Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age.

With US Centers for Disease Control and Prevention funding, from 2018 to 2022, 4 large healthcare systems (n = 53 health centers across 7 states) serving people of reproductive age trained staff and provided implementation support for alcohol screening and brief intervention (SBI). This cross-site evaluation explores each healthcare system's implementation approach to implement SBI, reduce excessive alcohol use, and prevent prenatal alcohol exposure (PAE) and fetal alcohol spectrum disorders. The SBIRT (Screening, Brief Intervention, and Referral to Treatment) Program Matrix framed the multilevel strategies to implement alcohol SBI programs from 2018 to 2022. Qualitative and quantitative data sources examined outcomes, guided by one logic model, through systems-level process data and provider-level performance metrics. Data analyses utilized frequencies and means for quantitative data and themes for qualitative data according to an established framework. Successful approaches within systems included using electronic health records, flexible implementation and workflow protocols, customized training and technical assistance programs, quality assurance feedback loops, and stakeholder buy-in. Centralized management structures were efficient in standardizing implementation across health centers. Decentralized management structures used tailored approaches, enhancing provider/staff SBI acceptance. Across systems, 1259 staff (eg, clinicians, medical assistants) were trained to provide alcohol SBI services and reported pre-post training increases in self-efficacy in performing brief intervention; skills in PAE counseling; and confidence in screening. Fifty-three (48 providing data) health centers implemented alcohol SBI, screening 106 826 patients over the study period with most of the 10 087 patients who screened positive for excessive alcohol use receiving a BI. Maximizing the use of technology, employing flexibility in program delivery, and institutionalizing processes and protocols improved workflow, efficiency, and program reach. Ongoing partnership and stakeholder communication identify areas for ongoing improvement, engagement, and best practices for sustainability around substance use screening, which are essential with increases in substance use since the pandemic.

Awareness of Social Functioning in People with Dementia and Its Association with Dementia Severity: Multi-Center Cross-Sectional Study.

People with dementia commonly have impaired social functioning and may not recognize this. This lack of awareness may result in worse outcomes for the person and their family carers. We aimed to characterize awareness of social functioning in dementia and describe its association with dementia severity. Multi-center cross-sectional study of people aged >65 years with dementia and family informants recruited from Germany, Japan and the United Kingdom. We used the Social Functioning in Dementia (SF-DEM) scale, assessing "spending time with other people" (domain 1), "communicating with other people" (domain 2), and "sensitivity to other people" (domain 3), and calculated lack of awareness into social functioning as the discrepancy between patient and informant ratings. 108 participants with dementia (50.9% women), mean age = 78.9 years, and mean MMSE score = 22.7. Patient and informant domain 1 ratings did not differ, but patient-rating was higher than carers for domain 2 (11.2 versus 10.1; p = 0.003) and domain 3 (9.7 versus 8.1; p < 0.001). Sixty people with dementia overestimated their overall social functioning, 30 underestimated, and 18 gave ratings congruent with their informant. Performance on the MMSE and its sub-domains was not associated with SF-DEM discrepancy score. We found that awareness of social functioning in dementia was a multidimensional concept, which varies according to subdomains of social functioning. Clinicians should help family members understand and adapt by explaining their relative with dementia's lack of awareness about aspects of their social functioning.

Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia

BackgroundA definition of the immunological features of COVID-19 pneumonia is needed to support clinical management of aged patients. In this study, we characterized the humoral and cellular immune responses in presence or absence of SARS-CoV-2 vaccination, in aged patients admitted to the IRCCS San Raffaele Hospital (Italy) for COVID-19 pneumonia between November 2021 and March 2022.MethodsThe study was approved by local authorities. Disease severity was evaluated according to WHO guidelines. We tested: (A) anti-SARS-CoV-2 humoral response (anti-RBD-S IgG, anti-S IgM, anti-N IgG, neutralizing activity against Delta, BA1, BA4/5 variants); (B) Lymphocyte B, CD4 and CD8 T-cell phenotype; (C) plasma cytokines. The impact of vaccine administration and different variants on the immunological responses was evaluated using standard linear regression models and Tobit models for censored outcomes adjusted for age, vaccine doses and gender.ResultWe studied 47 aged patients (median age 78.41), 22 (47%) female, 33 (70%) older than 70 years (elderly). At hospital admission, 36% were unvaccinated (VACno), whilst 63% had received 2 (VAC2) or 3 doses (VAC3) of vaccine. During hospitalization, WHO score > 5 was higher in unvaccinated (14% in VAC3 vs. 43% in VAC2 and 44% VACno). Independently from vaccination doses and gender, elderly had overall reduced anti-SARS-CoV-2 humoral response (IgG-RBD-S, p = 0.0075). By linear regression, the anti-RBD-S (p = 0.0060), B (p = 0.0079), CD8 (p = 0.0043) and Th2 cell counts (p = 0.0131) were higher in VAC2 + 3 compared to VACno. Delta variant was the most representative in VAC2 (n = 13/18, 72%), detected in 41% of VACno, whereas undetected in VAC3, and anti-RBD-S production was higher in VAC2 vs. VACno (p = 0.0001), alongside neutralization against Delta (p = 0141), BA1 (p = 0.0255), BA4/5 (p = 0.0162). Infections with Delta also drove an increase of pro-inflammatory cytokines (IFN-α, p = 0.0463; IL-6, p = 0.0010).ConclusionsAdministration of 3 vaccination doses reduces the severe symptomatology in aged and elderly. Vaccination showed a strong association with anti-SARS-CoV-2 humoral response and an expansion of Th2 T-cells populations, independently of age. Delta variants and number of vaccine doses affected the magnitude of the humoral response against the original SARS-CoV-2 and emerging variants. A systematic surveillance of the emerging variants is paramount to define future vaccination strategies.

Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials.

Insomnia is more common as people age. Several common hypnotics used to treat insomnia often do not adequately alleviate sleep issues in older adults and may be associated with negative residual effects such as an increased risk of falls, cognitive impairment, automobile accidents, and lack of response to auditory stimuli. The objective of these analyses of three clinical studies was to investigate the efficacy and safety of the dual orexin-receptor antagonist lemborexant (LEM) in older adults. Study E2006-G000-304 (Study 304; NCT02783729) was a randomized, double-blind, placebo (PBO)-controlled, active-comparator trial where subjects with insomnia disorder received LEM 5 mg (LEM5), LEM 10 mg (LEM10), zolpidem tartrate extended-release 6.25 mg (ZOL), or PBO for 30 days. In crossover Study E2006-E044-106 (Study 106; NCT02583451), healthy subjects (good sleepers) received LEM 2.5 mg, LEM5, LEM10, or PBO for eight nights or zopiclone on days 1 and 8 (and PBO on days 2-7). In crossover Study E2006-A001-108 (Study 108; NCT03008447), healthy subjects received a single dose of LEM5, LEM10, PBO, or ZOL. Sleep assessments included polysomnography-based latency to persistent sleep (LPS), wake after sleep onset (WASO), WASO in the second half of the night (WASO2H), sleep efficiency, postural stability, middle-of-the-night and next-day cognitive performance, middle-of-the-night auditory awakening threshold and return-to-sleep latency, and driving performance. Overall, 453 of 1006 (45%; Study 304), 24 of 48 (50%; Study 106), and 28 of 56 (50%; Study 108) subjects were aged ≥ 65years. In Study 304, LEM decreased (improved) LPS, WASO, and WASO2H from baseline more than ZOL and PBO; subjects treated with LEM had greater increases in sleep efficiency (improved) than with ZOL or PBO. In both Studies 304 and 108, postural stability was not impaired at waketime in subjects who received LEM compared with PBO. At waketime, LEM did not impair memory compared with PBO. In Study 108, following middle-of-the-night awakening, LEM and ZOL did not affect subjects' ability to awaken to auditory stimuli; LEM did not affect tests of memory and attention. In Study 106, LEM did not impair next-day driving performance in healthy elderly compared with PBO. LEM was well tolerated in subjects aged ≥ 65years. LEM provided benefits on sleep variables without next-morning residual effects in subjects aged ≥ 65years, supporting LEM as a treatment option for older adults with insomnia. Study 304: ClinicalTrials.gov identifier, NCT02783729, date of registration, 26 May 2016. Study 106: ClinicalTrials.gov identifier, NCT02583451, date of registration, 22 October 2015. Study 108: ClinicalTrials.gov identifier, NCT03008447, date of registration, 2 January 2017.

Influenza Vaccination Practices and Perceptions Among Young Athletes: A Cross-Sectional Study in Greece.

Influenza vaccination among athletes is a crucial area in sports medicine. This descriptive, cross-sectional study aims to explore the vaccination practices and intentions regarding influenza vaccines among young athletes. A structured, questionnaire-based study was conducted among students from the National School of Sports in Greece. The survey was conducted over the period of April to May 2023. Overall, 138 participants participated in the study. More than half of the participants had received a flu vaccine in the past, but only 12.3% were vaccinated against influenza for 2022-2023. The main reasons seemed to be the lack of time (40.6%) and the idea that influenza does not lead to any serious health threats for the participants (36.2%). The main factor that affected their decision to get the flu vaccine or not was the need for more information regarding influenza vaccination (79%). The recent study showed low vaccination coverage among people of young age participating in sports activities. The qualitative views of the participants highlighted the significance of the lackof a well-organized information program provided by health professionals and coaches.

Stroke Death Rates Among Adults Ages 45-64 by Region and Race and Hispanic Origin: United States, 2002-2022.

This Data Brief presents trends in stroke death rates among people ages 45-64, in total and by sex, for 2002 to 2022. Trends are also presented for men and women by region (Northeast, Midwest, South, and West) from 2002 to 2022. For 2022, stroke death rates are presented for men and women by race and Hispanic origin within each region. Mortality data for 2002-2017 are from the National Center for Health Statistics' 1999-2020 Underlying Cause of Death by Bridged-Race Categories and data for 2018-2022 are from the 2018-2022 Underlying Cause of Death by Single-Race Categories. Stroke deaths are for people ages 45-64 and are identified by International Classification of Diseases, 10th Revision underlying cause-of-death codes I60-I69. The four regions of the United States are: Northeast, Midwest, South, and West. The four race and Hispanic-origin groups in this report are: Asian non-Hispanic; Black non-Hispanic; White non-Hispanic, and Hispanic. These groups had at least 20 stroke deaths among men and women in all regions to compute reliable rates. Line trends were evaluated using the National Cancer Institute's Joinpoint Regression Program. Pairwise comparisons were tested using the z test statistic at p < 0.05. After declines between 2002 and 2012, stroke death rates for adults ages 45-64 increased 7% between 2012 (20.2 per 100,000) and 2019 (21.7) and an additional 12% through 2021 (24.4). Throughout the period, the highest stroke death rates for both men and women were in the South and the lowest were in the Northeast. In each region, differences in stroke death rates by race and Hispanic origin were seen, as Black men and women had rates that were at least twice those of all other groups.

2144 Improving PA students confidence in managing geriatric patients with a bespoke teaching programme and a novel bleep simulation

Abstract Introduction BGS reports in its ‘Case for more Geriatricians’ that the number of people age over 85 is set to double by 2045. As well as Geriatric specific policies in the Ageing Well programme of the NHS Longterm Workforce Plan there are plans to expand the number of allied health professionals including Physician Associates (PA). We set out to improve PA students’ knowledge of and confidence in managing geriatric patients with a bespoke teaching programme culminating in a novel bleep simulation. Methods We identified the students’ needs with a preliminary survey and then created a teaching programme on medical topics and issues common to geriatric wards with weekly lectures and small group work. The programme culminated in a bleep simulation where students were contacted via bleep to come to different parts of the medical education centre and respond to scenarios which would be common on geriatric wards. These included reviewing unwell patients and issues such as aspiration, constipation and urinary retention. The students were required to amend or create prescriptions and interpret test results with access to the BNF and relevant local guidelines. Results Students were asked how useful the simulation was and how much it had improved their confidence in working on geriatric wards. The average score for both statements was greater than 9/10. The students were asked before and after the simulation how confident they were responding to bleeps and managing clinical scenarios in geriatric patients. Both scores doubled following the simulation to 6.7/10 (from 2.5 and 3.3 respectively). Conclusion The Faculty of Physician Associates curriculum does not necessitate placements in geriatrics and its matrix of core clinical conditions does not include any specific to geriatrics. Through a bespoke teaching programme and a novel bleep simulation we increased PA students’ confidence in managing geriatric patients.

Health Aspects of Amateur Long-Distance Running

Introduction: Running, as a generally accessible form of physical activity, is recognized as a popular means of preventing lifestyle diseases. Each year, an increasing number of people of various ages, levels of training, and physical fitness participate in mass running events. Purpose: The study aims to identify the opinions of amateur long-distance runners regarding health. Material: 140 individuals from several Polish provinces, approximately 30 years old. Method: A proprietary questionnaire survey. Results: The most important factor motivating the respondents to engage in long-distance running is the improvement of sports performance, followed by the need to relieve stress, improve quality of life, and, to a lesser extent, health goals. According to most respondents, endurance-based long-distance running is healthy because it improves physical fitness, positively affects the cardiovascular and respiratory systems, enhances immunity, and is a way to relieve stress. Only a few respondents believe that running is not healthy. The main forms of preparation for half marathons and marathons among runners include warm-up exercises before the planned effort and strength and muscle stretching exercises. In the studied group of runners, past injuries do not diminish the satisfaction of engaging in long-distance running. Despite a significant number of respondents having experienced injuries in the past while practicing this sport, they still consider running to be healthy. Conclusions: Long-distance running brings numerous health benefits. It improves physical fitness, positively affects cardiovascular function, including lowering blood pressure, significantly enhances sleep quality, and helps reduce stress, as confirmed by the respondent’s opinions.

Nutritional status in the era of highly effective CFTR modulators.

Advances in cystic fibrosis (CF) diagnostics and therapeutics have led to improved health and longevity, including increased body weight and decreased malnutrition in people with CF. Highly effective CFTR modulator therapies (HEMT) are associated with increased weight through a variety of mechanisms, accelerating trends of overweight and obesity in the CF population. Higher body mass index (BMI) is associated with improved pulmonary function in CF, yet the incremental improvement at overweight and obese BMIs is not clear. Improvements in pulmonary health with increasing BMI are largely driven by increases in fat-free mass (FFM), and impact of HEMT on FFM is uncertain. While trends toward higher weight and BMI are generally seen as favorable in CF, the increased prevalence of overweight and obesity has raised concern for potential risk of traditional age- and obesity-related comorbidities. Such comorbidities, including impaired glucose tolerance, hypertension, cardiac disease, hyperlipidemia, fatty liver, colon cancer, and obstructive sleep apnea, may occur on top of pre-existing CF-related comorbidities. CF nutrition recommendations are evolving in the post-modulator era to more individualized approaches, in contrast to prior blanket high-fat, high-calorie prescriptions for all. Ultimately, it will be essential to redefine goals for optimal weight and nutritional status to allow for holistic health and aging in people with CF.

Young People's Support for and Personal Interest in an Advance Provision Model for Medication Abortion

PurposeTo assess young people's interest in advance provision (AP) of medication abortion—receiving mifepristone and misoprostol from a clinician in advance for their future use. MethodsFrom November 2022-August 2023 we administered an electronic survey regarding advance provision to patients assigned female at birth at four Bay Area youth-serving clinics. ResultsAmong 152 people ages 14-24 years (mean 17.9) surveyed, 73.7% (95% CI, 65.9%-80.5%) supported and 46.1% (95% CI, 37.9%-54.3%) were interested in the AP model. AP interest was higher among people who experienced three or more difficulties trying to access reproductive healthcare (70.6% [95% CI, 44.0%-89.7%]) and who experienced food or housing insecurity (60.3% [95% CI, 46.6%-73.0%]). Most youth (81.6%) had a safe place to store the pills for later use; this proportion was significantly higher among people ages 18-24 years (88.5%) than teens ages 14-17 years (74.3%, P = .025). The most common perceived advantages of AP included being able to have the abortion earlier in pregnancy (61.8%), privacy (57.9%) and convenience (50.7%). Common disadvantages noted included concern that people might take the pills incorrectly (50.0%) or lose the pills (40.1%). ConclusionsYoung people have considerable interest in AP of medication abortion. Further research is needed to document the AP model's feasibility, clinical outcomes, and effect on access for adolescents.

Senotherapy preserves resilience in aging.

In aging societies, social and economic burdens of aging-related diseases are increasing significantly. Senotherapy, which targets aging by eliminating senescent cells (senolytics) or removing sources of chronic inflammation (senostatics), are proposed as novel strategies for aging-related diseases. Aged or frail people suffer a decline of tissue reserve capacity during aging. Resilience, which is much reduced in older people, is essential for recovery from diseases, stresses or crises. Impaired resilience is one of the reasons why aged people experience a gradual waning of their daily activity and an increase of multimorbidity. Calorie restriction results in senostatic alleviation of chronic inflammation, whereas senolytic drugs induce apoptosis of senescent cells, which exacerbate aging by excreting inflammatory factors. Thus, both senolytics and senostatics are expected to reduce sterile inflammation, originating from senescent cells. Geriatr Gerontol Int 2024; ••: ••-••.

Histological Changes in Dental Pulp During the Aging Process: Implications for Endodontic Treatment

on the results of endodontic treatment. Knowledge of these changes is essential in order to design treatment strategies that allow aging people a life with constant dental health. Objective: The objective of this study sought to perform an analysis of the histological changes that occur within dental pulp as a result of aging. Study Design: This is a cross-sectional study. Duration and Place of the Study: This study was conducted at Department Anatomy of General Hospital and Research Centre, Peshawar, from 3rd November 2022 to 2nd December 2023. Material and Methods: A total of 220 patients aged between 20-80 years, were admitted to this survey. According to age, they were classified into 20-29 years (n=41), 30-39 years (n=39),40-49 years (n=48), 50-59 years (n=45 ) and 60 -80 years( n=47). Extraction of dental pulp samples Pulp tissues were harvested from teeth that had been extracted for non-dental reasons. Histological analysis for cellularity, vascularity and fibrous content of the pulp tissue. Results: A total of 220 patients aged between 20 and 80 Years were included in this study. The biggest group of people was participants 40-49 years old (21.8%), and the smallest one is for 30-39-year-olds with (17.7%). The study found that Participants of the age groups 20–29 years showed a mean cellularity (1500 cells/mm²), with standard deviation of ±200, while those in the 60-80 years group had the lowest mean cellularity at 800 cells/mm² with a standard deviation of ±160. Conclusion: The histological changes in dental pulp with ageing have as consequences implications on endodontic treatment. Keywords: Dental Pulp, Histological Changes, Endodontic Treatment Implications

UnboXing relationships and sexuality education with a phEmaterialist arts-activist praxis

ABSTRACT Inspired by posthuman, feminist materialist theory-doings in educational research, this paper maps moments in a post-qualitative research project that set out to explore what else relationships and sexuality education might become with ‘art-as-way’ (Manning 2020) in a shaky yet conducive policy context where ‘what matters’ must not be assumed in advance but co-constructed with children and young people. Progressively supported by an artist-in-residence teacher assistant, composer and filmmaker, we open up what unfolds when a diverse group of 11 young people (age 13–14) creatively unbox and make ‘what matters’ to them in an art classroom. We conceptualize what came to matter as ‘dartaphacts’ (arts-activist objects) and follow these other-worldly posthuman pARTicipants as they connect, grow, and become ‘more-than’. We speculate, that in conducive, con-sense-ual environments, the affective power of dartaphacts can unbox a living curriculum for a Relationships and Sexuality Education (RSE) to come, in all its Majestic Insecurity, Untitled, Freedoms, Feathers, Bruised Hearts, Consent-quakes, eQuality Vibrations and Wiggly Woos.

Dysphagia: causes, diagnosis and treatment – an update for practice nurses

The number of people with dysphagia is rising in line with population ageing. It is now thought to affect around 5.2 million people in the UK, one adult in 8 ( Boaden et. al, 2019 ). It becomes more common as people age and is associated with neurological problems, frailty and poor outcomes ( Patel et. al, 2018 : Cohen et. al, 2021 ). This article aims to update practice nurses on the clinical features of dysphagia, how to identify it, when to refer and how it is managed. As many as one adults in eight in the UK are affected by dysphagia. Linda Nazarko looks at what nurses need to know when managing this condition.

MS treatment de-escalation: review and commentary.

Almost all currently licensed disease-modifying therapies (DMTs) for MS treatment require prolonged if not lifelong administration. Yet, as people age, the immune system has increasingly reduced responsiveness, known as immunosenescence. Many MS DMTs reduce the responsiveness of the immune system, increasing the risks for infections and possibly cancers. As people with MS (pwMS) age, it is recognized that inflammatory MS activity declines. Several studies have addressed de-escalation of DMTs for relapsing MS under special circumstances. Here, we review evidence for de-escalating DMTs as a strategy that is particularly relevant to pwMS of older age. Treatment de-escalation can involve various strategies, such as extended or reduced dosing, switching from high-efficacy DMTs having higher risks to moderately effective DMTs with lesser risks, or treatment discontinuation. Studies have suggested that for natalizumab extended dosing maintained clinical efficacy while reducing the risk of PML. Extended interval dosing of ocrelizumab mitigated the decline of Ig levels. Retrospective and observational discontinuation studies demonstrate that age is an essential modifier of drug efficacy. Discontinuation of MS treatment in older patients has been associated with a stable disease course, while younger patients who discontinued treatment were more likely to experience new clinical activity. A recently completed 2-year randomized-controlled discontinuation study in 260 stable pwMS > 55years found stable clinical multiple sclerosis with only a small increased risk of new MRI activity upon discontinuation. DMT de-escalation or discontinuation in MS patients older than 55years may be non-inferior to continued treatment with immunosuppressive agents having higher health risks. However, despite several small studies, a definite conclusion about treatment de-escalation in older pwMS will require larger and longer studies. Ideally, comparison of de-escalation versus continuation versus discontinuation of DMTs should be done by prospective randomized-controlled trials enrolling sufficient numbers of subjects to allow comparisons for MS patients of both sexes within age groups, such as 55-59, 60-65, 66-69, etc. Optimally, such studies should be 3years or longer and should incorporate testing for specific markers of immunosenescence (such as T-cell receptor excision circles) to account for differential aging of individuals.

Eight Great Models Help People Age in Place

Eight Great Models Help People Age in Place